American Heart Association commends CMS decision on supervised exercise therapy for peripheral artery disease
Washington, D.C., May 25, 2017 — American Heart Association CEO Nancy Brown issued the following comments today on the Centers for Medicare and Medicaid Services’ (CMS) final decision on Medicare coverage for supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD):
“We are so pleased that patients with peripheral artery disease (PAD) will now be able to receive supervised exercise therapy (SET) through Medicare. PAD affects 12 to 20 percent of Americans age 60 and older, and the incidence of PAD increases considerably with age. Medicare beneficiaries, a significant portion of which have PAD, will benefit considerably from participating in supervised exercise therapy sessions. Evidence shows this therapy can improve quality of life for patients and enhance clinical outcomes.
The American Heart Association, along with many other stakeholders, have long recommended supervised exercise as a first‐line, non‐invasive, low risk therapy for individuals with PAD. The Association has advocated for it since our first PAD guidelines were issued in 2005, and just last year, we filed a National Coverage Determination request asking CMS for this exact outcome.
We couldn’t be more thrilled with today’s decision that will give more Americans the access they need to this important treatment option.”
Contact: Abbey Dively (202) 785-7905; firstname.lastname@example.org